Abstract:Advances in catheter-based ultrasound imaging technology allow for a unique opportunity to develop two-dimensional intracardiac echocardiography, an imaging method that could have significant clinical applications. In this study, we evaluated the potential of a new, percutaneous, 9-Fr prototype intracardiac echocardiographic catheter with a 12.5-MHz rotating crystal in 13 dogs. In all dogs, we were able to easily advance the intracardiac echocardiographic catheter into the right and left hearts percutaneousl… Show more
“…To explore the potential of ICE using relatively lower frequency ultrasound catheters, we employed a mechanically rotating 12.5 MHz ultrasound catheter in animals and humans [48][49][50]. The ultrasound catheter we used is a prototype device (Son- icath, Boston Scientific Corp., Watertown, Massachusetts) that consists of an outer 9F or 6F disposable catheter enclosing a mechanically rotatable driveshaft with the ultrasound crystal at its tip.…”
Section: Intracardiac Echocardiography Using Low-frequency Ultrasoundmentioning
Intracardiac echocardiography refers to the method of imaging cardiac structures from intracardiac locations with the use of ultrasound catheters. Advances in catheter-based interventional cardiologic procedures to treat cardiovascular lesions and the problems encountered during those procedures due to inadequate guidance provided by fluoroscopy have given the impetus to develop other guidance modalities. Experimental explorations with intracardiac ultrasound probes have indicated that detailed visualization of cardiac structures in real-time is possible by intracardiac ultrasound. Recent advances in catheter-based ultrasound technology make it feasible to safely pass small-sized catheters in humans into various intracardiac locations and acquire images of valvular structures and various chambers. Experience with 20 MHz ultrasound catheters indicates that high resolution images of normal and abnormal structures can be obtained if the catheter is manipulated close to the region of interest. The problem of the limited depth of field associated with 20 MHz catheters has led to the fabrication of catheters with lower frequency ultrasound elements. Experimental and clinical experience with 12.5 MHz ultrasound catheters points to the capability and potential of intracardiac echocardiography to not only display normal structures but also aid in the identification of valvular abnormalities, chamber dysfunction and pericardial effusions. In addition, aortic disorders such as acute dissection, coarctation and atherosclerotic disease could be delineated. Similarly, abnormalities involving the pulmonary arteries such as pulmonary embolism, organized thrombi, peripheral pulmonary arterial stenoses, and pulmonary hypertension-induced vascular changes could be recognized. Many modifications in the catheter design are being explored. With further work in the area of catheter technology and ultrasound image processing, intracardiac echocardiography is likely to become a clinical tool.
“…To explore the potential of ICE using relatively lower frequency ultrasound catheters, we employed a mechanically rotating 12.5 MHz ultrasound catheter in animals and humans [48][49][50]. The ultrasound catheter we used is a prototype device (Son- icath, Boston Scientific Corp., Watertown, Massachusetts) that consists of an outer 9F or 6F disposable catheter enclosing a mechanically rotatable driveshaft with the ultrasound crystal at its tip.…”
Section: Intracardiac Echocardiography Using Low-frequency Ultrasoundmentioning
Intracardiac echocardiography refers to the method of imaging cardiac structures from intracardiac locations with the use of ultrasound catheters. Advances in catheter-based interventional cardiologic procedures to treat cardiovascular lesions and the problems encountered during those procedures due to inadequate guidance provided by fluoroscopy have given the impetus to develop other guidance modalities. Experimental explorations with intracardiac ultrasound probes have indicated that detailed visualization of cardiac structures in real-time is possible by intracardiac ultrasound. Recent advances in catheter-based ultrasound technology make it feasible to safely pass small-sized catheters in humans into various intracardiac locations and acquire images of valvular structures and various chambers. Experience with 20 MHz ultrasound catheters indicates that high resolution images of normal and abnormal structures can be obtained if the catheter is manipulated close to the region of interest. The problem of the limited depth of field associated with 20 MHz catheters has led to the fabrication of catheters with lower frequency ultrasound elements. Experimental and clinical experience with 12.5 MHz ultrasound catheters points to the capability and potential of intracardiac echocardiography to not only display normal structures but also aid in the identification of valvular abnormalities, chamber dysfunction and pericardial effusions. In addition, aortic disorders such as acute dissection, coarctation and atherosclerotic disease could be delineated. Similarly, abnormalities involving the pulmonary arteries such as pulmonary embolism, organized thrombi, peripheral pulmonary arterial stenoses, and pulmonary hypertension-induced vascular changes could be recognized. Many modifications in the catheter design are being explored. With further work in the area of catheter technology and ultrasound image processing, intracardiac echocardiography is likely to become a clinical tool.
“…In TEE, the blood flow from the periphery of the occluder to the residual cavity of the LAA can be observed. 4 In patients with EIS, blood flow can be observed only in the residual cavity of the LAA; it cannot be observed at the periphery of the occluder. However, some patients cannot tolerate the TEE examination because it takes a long time to perform and is associated with a risk of esophageal damage.…”
Section: Introductionmentioning
confidence: 98%
“…The traditional method for differentiating between EIS and PDL is transesophageal echocardiography (TEE). In TEE, the blood flow from the periphery of the occluder to the residual cavity of the LAA can be observed 4 . In patients with EIS, blood flow can be observed only in the residual cavity of the LAA; it cannot be observed at the periphery of the occluder.…”
IntroductionThis study was performed to explore the diagnostic value of cardiac computed tomography angiography (CCTA) for endothelial insufficiency (EIS) of a left atrial appendage (LAA) disc‐like occluder.MethodsFifty‐nine patients with nonvalvular atrial fibrillation who underwent placement of an LAA disc‐like occluder (LAmbre; Lifetech Scientific) in our hospital were retrospectively analyzed. Patients who were found to have contrast agent entering the LAA at the 3‐month postoperative CCTA examination underwent Hounsfield unit (HU) measurement of the LAA and construction of a three‐dimensional (3D) model of the device for preliminary discernment between peri‐device leakage (PDL) and EIS. These patients were then further examined by transesophageal echocardiography (TEE) to check for concordance with the computed tomography (CT) findings. According to the CT and TEE results, all patients were divided into the PDL group, total endothelialization group, and EIS group. The endothelial conditions and other implantation‐related results were also tracked at the 6‐month follow‐up.ResultsAll 59 patients underwent successful implantation of the LAmbre LAA closure device with no severe adverse events during the procedure. Thirty‐five patients were found to have contrast agent entering the LAA at the 3‐month postoperative CCTA follow‐up. Based on the CT HU measurement and the 3D construction analysis results, these 35 patients were divided into the PDL group (19 patients) and the EIS group (16 patients). In the PDL group, the contrast agent infiltrated from the shoulder along the periphery of the occluder on two‐dimensional (2D) CT images, and the 3D model showed a gap between the LAA and the device cover. However, the CCTA images of the other 16 patients in the EIS group showed that the contrast agent in the occluder on the 2D CTA images and 3D construction model confirmed the absence of a gap between the LAA and the device cover. TEE confirmed all of the CT results. The 6‐month follow‐up results showed that 14 of 19 patients in the EIS group achieved total endothelialization, whereas this number in the PDL group was only five of 19 patients.ConclusionCCTA can replace TEE for examination of the endothelialization status, and patients with EIS have a higher chance of endothelialization than patients with PDL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.